F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Steatosis

Page 1 of 2 ( 86 items )
<<
1
2
>>

1	Blood markers vs transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease 1/27/2026 10:12:32 AM \| Browse: 237 \| Download: 553
2	Phase III, multicenter, randomized, double-blind, placebo-controlled study of norursodeoxycholic acid in metabolic dysfunction-associated steatotic liver disease patients 12/26/2025 10:27:34 AM \| Browse: 342 \| Download: 694
3	Mitochondrial transplantation and platelet rich plasma for the treatment of non-alcoholic fatty liver disease 10/27/2025 10:57:53 AM \| Browse: 386 \| Download: 652
4	Impact of donor obesity on paediatric liver transplantation; current evidence and potentials for graft pool expansion 4/18/2025 8:22:26 AM \| Browse: 162 \| Download: 522
5	Hepatic-specific vitamin D receptor downregulation alleviates aging-related metabolic dysfunction-associated steatotic liver disease 4/11/2025 2:19:32 AM \| Browse: 301 \| Download: 1227
6	Prospects of elafibranor in treating alcohol-associated liver diseases 12/18/2024 7:36:02 AM \| Browse: 240 \| Download: 775
7	Suppression of hepatic steatosis in non-alcoholic steatohepatitis model by modified Xiaoyao San formula: Evidence, mechanisms and perspective 10/21/2024 7:03:25 AM \| Browse: 228 \| Download: 710
8	Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography 12/6/2023 8:08:49 AM \| Browse: 573 \| Download: 1710
9	Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease 5/24/2023 9:31:05 AM \| Browse: 600 \| Download: 1504
10	Pancreatic fat in type 2 diabetes: Causal or coincidental? 3/1/2023 6:11:27 AM \| Browse: 612 \| Download: 1360
11	Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring 7/4/2022 12:30:52 PM \| Browse: 794 \| Download: 1699
12	Metabolic aspects of hepatitis C virus 6/10/2022 5:40:20 AM \| Browse: 803 \| Download: 1966
13	Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis 4/29/2022 11:12:04 AM \| Browse: 854 \| Download: 1644
14	Glycogen hepatopathy in type-1 diabetes mellitus: A case report 2/22/2022 9:25:38 AM \| Browse: 783 \| Download: 1577
15	Nonalcoholic fatty liver disease shows significant sex dimorphism 2/11/2022 5:55:19 AM \| Browse: 773 \| Download: 2032
16	Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence 1/21/2022 8:16:14 AM \| Browse: 1009 \| Download: 1980
17	Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit? 10/20/2021 7:18:39 AM \| Browse: 822 \| Download: 1437
18	Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist? 9/7/2021 8:15:21 AM \| Browse: 1083 \| Download: 1774
19	Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study 8/4/2021 7:56:20 AM \| Browse: 922 \| Download: 2385
20	Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion 7/12/2021 12:42:13 AM \| Browse: 1069 \| Download: 2183
21	PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease 7/6/2021 2:31:17 AM \| Browse: 985 \| Download: 2688
22	Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis 6/18/2021 5:06:16 AM \| Browse: 1010 \| Download: 2183
23	Frequency of hepatic steatosis and its association with the pneumonia severity score on chest computed tomography in adult COVID-19 patients 5/8/2021 7:57:00 AM \| Browse: 1008 \| Download: 2142
24	Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand? 3/18/2021 10:54:40 AM \| Browse: 1125 \| Download: 1764
25	Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study 2/5/2021 10:20:18 AM \| Browse: 1081 \| Download: 3184
26	Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo 11/24/2020 12:41:21 PM \| Browse: 1100 \| Download: 2467
27	Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis 11/6/2020 7:36:12 AM \| Browse: 1213 \| Download: 2872
28	Liver fat accumulation measured by high-speed T2-corrected multi-echo magnetic resonance spectroscopy can predict risk of cholelithiasis 9/4/2020 7:25:49 AM \| Browse: 1100 \| Download: 3040
29	Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we 8/7/2019 7:09:17 AM \| Browse: 1420 \| Download: 1980
30	Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease 7/28/2019 10:51:57 AM \| Browse: 1389 \| Download: 1658
31	Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease 6/28/2019 12:22:27 PM \| Browse: 1629 \| Download: 2899
32	Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice 3/20/2019 5:32:10 AM \| Browse: 1648 \| Download: 2512
33	Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects 2/26/2019 11:29:04 AM \| Browse: 1593 \| Download: 2299
34	Chronic hepatitis B and metabolic risk factors: A call for rigorous longitudinal studies 1/21/2019 5:38:30 AM \| Browse: 1524 \| Download: 1994
35	Current status, problems, and perspectives of non-alcoholic fatty liver disease research 1/14/2019 2:54:12 PM \| Browse: 1714 \| Download: 2441
36	Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease 12/27/2018 8:56:32 AM \| Browse: 1386 \| Download: 2464
37	Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease 9/25/2018 3:44:36 AM \| Browse: 1548 \| Download: 2326
38	Feasibility of using marginal liver grafts in living donor liver transplantation 6/15/2018 9:13:16 AM \| Browse: 1636 \| Download: 2094
39	Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction 4/27/2018 3:25:40 AM \| Browse: 1654 \| Download: 2104
40	Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals 3/16/2018 12:27:25 PM \| Browse: 1695 \| Download: 3107
41	circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling 1/19/2018 9:46:49 AM \| Browse: 1512 \| Download: 2528
42	Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease 6/20/2017 12:12:52 PM \| Browse: 1669 \| Download: 2451
43	Non-alcoholic fatty liver disease: An expanded review 6/6/2017 12:54:56 AM \| Browse: 1947 \| Download: 2089
44	Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease 5/20/2017 12:26:24 PM \| Browse: 2030 \| Download: 2175
45	Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice 5/16/2017 6:56:36 AM \| Browse: 1919 \| Download: 3240
46	Non-alcoholic fatty liver disease and cardiovascular risk 5/16/2017 6:56:36 AM \| Browse: 1849 \| Download: 2032
47	Changes in human hepatic metabolism in steatosis and cirrhosis 4/20/2017 3:58:56 PM \| Browse: 2115 \| Download: 3344
48	Association between endotoxemia and histological features of nonalcoholic fatty liver disease 1/19/2017 11:16:00 AM \| Browse: 1946 \| Download: 2797
49	Prevalence of significant liver disease in human immunodeficiency virus-infected patients exposed to Didanosine: A cross sectional study 12/27/2016 8:31:00 AM \| Browse: 2000 \| Download: 3589
50	Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV 11/26/2016 6:56:00 PM \| Browse: 1886 \| Download: 2433

Page 1 of 2 ( 86 items )
<<
1
2
>>

1	Blood markers vs transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease 1/27/2026 10:12:32 AM \| Browse: 237 \| Download: 553
2	Phase III, multicenter, randomized, double-blind, placebo-controlled study of norursodeoxycholic acid in metabolic dysfunction-associated steatotic liver disease patients 12/26/2025 10:27:34 AM \| Browse: 342 \| Download: 694
3	Mitochondrial transplantation and platelet rich plasma for the treatment of non-alcoholic fatty liver disease 10/27/2025 10:57:53 AM \| Browse: 386 \| Download: 652
4	Impact of donor obesity on paediatric liver transplantation; current evidence and potentials for graft pool expansion 4/18/2025 8:22:26 AM \| Browse: 162 \| Download: 522
5	Hepatic-specific vitamin D receptor downregulation alleviates aging-related metabolic dysfunction-associated steatotic liver disease 4/11/2025 2:19:32 AM \| Browse: 301 \| Download: 1227
6	Prospects of elafibranor in treating alcohol-associated liver diseases 12/18/2024 7:36:02 AM \| Browse: 240 \| Download: 775
7	Suppression of hepatic steatosis in non-alcoholic steatohepatitis model by modified Xiaoyao San formula: Evidence, mechanisms and perspective 10/21/2024 7:03:25 AM \| Browse: 228 \| Download: 710
8	Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography 12/6/2023 8:08:49 AM \| Browse: 573 \| Download: 1710
9	Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease 5/24/2023 9:31:05 AM \| Browse: 600 \| Download: 1504
10	Pancreatic fat in type 2 diabetes: Causal or coincidental? 3/1/2023 6:11:27 AM \| Browse: 612 \| Download: 1360
11	Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring 7/4/2022 12:30:52 PM \| Browse: 794 \| Download: 1699
12	Metabolic aspects of hepatitis C virus 6/10/2022 5:40:20 AM \| Browse: 803 \| Download: 1966
13	Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis 4/29/2022 11:12:04 AM \| Browse: 854 \| Download: 1644
14	Glycogen hepatopathy in type-1 diabetes mellitus: A case report 2/22/2022 9:25:38 AM \| Browse: 783 \| Download: 1577
15	Nonalcoholic fatty liver disease shows significant sex dimorphism 2/11/2022 5:55:19 AM \| Browse: 773 \| Download: 2032
16	Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence 1/21/2022 8:16:14 AM \| Browse: 1009 \| Download: 1980
17	Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit? 10/20/2021 7:18:39 AM \| Browse: 822 \| Download: 1437
18	Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist? 9/7/2021 8:15:21 AM \| Browse: 1083 \| Download: 1774
19	Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study 8/4/2021 7:56:20 AM \| Browse: 922 \| Download: 2385
20	Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion 7/12/2021 12:42:13 AM \| Browse: 1069 \| Download: 2183
21	PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease 7/6/2021 2:31:17 AM \| Browse: 985 \| Download: 2688
22	Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis 6/18/2021 5:06:16 AM \| Browse: 1010 \| Download: 2183
23	Frequency of hepatic steatosis and its association with the pneumonia severity score on chest computed tomography in adult COVID-19 patients 5/8/2021 7:57:00 AM \| Browse: 1008 \| Download: 2142
24	Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand? 3/18/2021 10:54:40 AM \| Browse: 1125 \| Download: 1764
25	Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study 2/5/2021 10:20:18 AM \| Browse: 1081 \| Download: 3184
26	Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo 11/24/2020 12:41:21 PM \| Browse: 1100 \| Download: 2467
27	Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis 11/6/2020 7:36:12 AM \| Browse: 1213 \| Download: 2872
28	Liver fat accumulation measured by high-speed T2-corrected multi-echo magnetic resonance spectroscopy can predict risk of cholelithiasis 9/4/2020 7:25:49 AM \| Browse: 1100 \| Download: 3040
29	Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we 8/7/2019 7:09:17 AM \| Browse: 1420 \| Download: 1980
30	Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease 7/28/2019 10:51:57 AM \| Browse: 1389 \| Download: 1658
31	Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease 6/28/2019 12:22:27 PM \| Browse: 1629 \| Download: 2899
32	Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice 3/20/2019 5:32:10 AM \| Browse: 1648 \| Download: 2512
33	Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects 2/26/2019 11:29:04 AM \| Browse: 1593 \| Download: 2299
34	Chronic hepatitis B and metabolic risk factors: A call for rigorous longitudinal studies 1/21/2019 5:38:30 AM \| Browse: 1524 \| Download: 1994
35	Current status, problems, and perspectives of non-alcoholic fatty liver disease research 1/14/2019 2:54:12 PM \| Browse: 1714 \| Download: 2441
36	Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease 12/27/2018 8:56:32 AM \| Browse: 1386 \| Download: 2464
37	Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease 9/25/2018 3:44:36 AM \| Browse: 1548 \| Download: 2326
38	Feasibility of using marginal liver grafts in living donor liver transplantation 6/15/2018 9:13:16 AM \| Browse: 1636 \| Download: 2094
39	Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction 4/27/2018 3:25:40 AM \| Browse: 1654 \| Download: 2104
40	Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals 3/16/2018 12:27:25 PM \| Browse: 1695 \| Download: 3107
41	circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling 1/19/2018 9:46:49 AM \| Browse: 1512 \| Download: 2528
42	Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease 6/20/2017 12:12:52 PM \| Browse: 1669 \| Download: 2451
43	Non-alcoholic fatty liver disease: An expanded review 6/6/2017 12:54:56 AM \| Browse: 1947 \| Download: 2089
44	Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease 5/20/2017 12:26:24 PM \| Browse: 2030 \| Download: 2175
45	Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice 5/16/2017 6:56:36 AM \| Browse: 1919 \| Download: 3240
46	Non-alcoholic fatty liver disease and cardiovascular risk 5/16/2017 6:56:36 AM \| Browse: 1849 \| Download: 2032
47	Changes in human hepatic metabolism in steatosis and cirrhosis 4/20/2017 3:58:56 PM \| Browse: 2115 \| Download: 3344
48	Association between endotoxemia and histological features of nonalcoholic fatty liver disease 1/19/2017 11:16:00 AM \| Browse: 1946 \| Download: 2797
49	Prevalence of significant liver disease in human immunodeficiency virus-infected patients exposed to Didanosine: A cross sectional study 12/27/2016 8:31:00 AM \| Browse: 2000 \| Download: 3589
50	Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV 11/26/2016 6:56:00 PM \| Browse: 1886 \| Download: 2433